‘‘(A) incorporating into such plan new 
knowledge or observations relating to hepatitis 
B (such as knowledge and observations that 
may be derived from clinical, laboratory, and 
epidemiological research and disease detection, 
prevention, and surveillance outcomes); and 
‘‘(B) addressing gaps in the coverage or ef-
fectiveness of the plan. 
‘‘(2) PUBLICATION
OF
NOTICE
OF
ASSESS-
MENTS.—Not later than October 1 of the first even 
numbered year beginning after the date of enact-
ment of this part, and October 1 of each even num-
bered year thereafter, the Secretary shall publish in 
the Federal Register a notice of the results of the 
assessments conducted under paragraph (1). Such 
notice shall include— 
‘‘(A) a description of any revisions to the 
plan developed under subsection (a) as a result 
of the assessment; 
‘‘(B) an explanation of the basis for any 
such revisions, including the ways in which such 
revisions can reasonably be expected to further 
promote the original goals and objectives of the 
plan; and 
VerDate Aug 31 2005 
06:07 Oct 25, 2007
Jkt 069200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6201
E:\BILLS\H3944.IH
H3944
bajohnson on PROD1PC71 with BILLS
‘‘(C) in the case of a determination by the 
Secretary that the plan does not need revision, 
an explanation of the basis for such determina-
tion. 
‘‘SEC. 399GG. ELEMENTS OF PROGRAM. 
‘‘(a) IMMUNIZATION, PREVENTION, AND CONTROL 
PROGRAMS.— 
‘‘(1) IN
GENERAL.—The Secretary, acting 
through the Director of the Centers for Disease 
Control and Prevention, shall support the integra-
tion of activities described in paragraph (2) into ex-
isting clinical and public health programs at State, 
local, and tribal levels (including Asian and non- 
Asian community health clinics, programs for the 
prevention and treatment of HIV/AIDS, sexually 
transmitted diseases, and substance abuse, and pro-
grams for individuals in correctional settings). 
‘‘(2) ACTIVITIES.— 
‘‘(A) VOLUNTARY TESTING PROGRAMS.— 
‘‘(i) IN
GENERAL.—The Secretary 
shall establish a mechanism by which to 
support and promote the development of 
State, local, and tribal voluntary hepatitis 
B testing programs to screen the high 
chronic hepatitis B prevalence populations 
VerDate Aug 31 2005 
06:07 Oct 25, 2007
Jkt 069200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6201
E:\BILLS\H3944.IH
H3944
bajohnson on PROD1PC71 with BILLS
(such as Asian Americans, new immigrants 
or foreign-born United States residents, 
and persons with one or both foreign-born 
parents) to aid in the early identification 
of chronically infected individuals. 
‘‘(ii) CONFIDENTIALITY OF THE TEST 
RESULTS.—The Secretary shall prohibit 
the use of the results of a hepatitis B test 
conducted by a testing program developed 
or supported under this subparagraph for 
any of the following: 
‘‘(I) Issues relating to health in-
surance. 
‘‘(II) To screen or determine 
suitability for employment. 
‘‘(III) To discharge a person 
from employment. 
‘‘(B) COUNSELING.—The Secretary shall 
support State, local, and tribal programs in a 
wide variety of settings, including those pro-
viding primary and specialty health care serv-
ices in the private and public sectors, to— 
‘‘(i) provide individuals with ongoing 
risk factors for hepatitis B infection with 
VerDate Aug 31 2005 
06:07 Oct 25, 2007
Jkt 069200
PO 00000
Frm 00009
Fmt 6652
Sfmt 6201
E:\BILLS\H3944.IH
H3944
bajohnson on PROD1PC71 with BILLS
client-centered education and counseling 
which concentrates on— 
‘‘(I) promoting testing of family 
members and their sexual partners; 
and 
‘‘(II) changing behaviors that 
place individuals at risk for infection; 
‘‘(ii) provide individuals chronically in-
fected with hepatitis B with education, 
health information, and counseling to re-
duce their risk of— 
‘‘(I) dying from end stage liver 
disease and liver cancer; and 
‘‘(II) transmitting viral hepatitis 
to others; and 
‘‘(iii) provide women chronically in-
fected with hepatitis B who are pregnant 
or in their childbearing age with culturally 
appropriate health information to alleviate 
fears associated with pregnancy or raising 
a family. 
‘‘(C) IMMUNIZATION.—The Secretary shall 
support State, local, and tribal efforts to ex-
pand the current vaccination programs to pro-
tect every child in the country and all suscep-
VerDate Aug 31 2005 
06:07 Oct 25, 2007
Jkt 069200
PO 00000
Frm 00010
Fmt 6652
Sfmt 6201
E:\BILLS\H3944.IH
H3944
bajohnson on PROD1PC71 with BILLS
tible adults, particularly those from the high- 
prevalence ethnic populations and other high 
risk groups, from the risks of acute and chronic 
hepatitis B infection by— 
‘‘(i) ensuring continued funding for 
hepatitis B vaccination for all children 19 
years of age or under through the Vaccines 
for Children Program; 
‘‘(ii) ensuring that the recommenda-
tions of the Advisory Committee on Immu-
nization Practices are followed regarding 
hepatitis B vaccinations for newborns; 
‘‘(iii) requiring proof of hepatitis B 
vaccination for entry into public or private 
day care, preschool, elementary school, sec-
ondary school, and institutions of higher 
education; 
‘‘(iv) expanding the availability of vac-
cines for all susceptible adults to protect 
them from becoming acutely or chronically 
infected, including ethnic populations with 
high prevalence rates of chronic hepatitis 
B infection; and 
‘‘(v) expanding the availability of vac-
cines for all susceptible adults, particularly 
VerDate Aug 31 2005 
06:07 Oct 25, 2007
Jkt 069200
PO 00000
Frm 00011
Fmt 6652
Sfmt 6201
E:\BILLS\H3944.IH
H3944
bajohnson on PROD1PC71 with BILLS
those in their reproductive age (women and 
men less than 45 years of age), from the 
risk of hepatitis B infection. 
‘‘(D) MEDICAL REFERRAL.—The Secretary 
shall support State, local, and tribal programs 
that support— 
‘‘(i) referral of persons chronically in-
fected with hepatitis B— 
‘‘(I) for medical evaluation to de-
termine 
the 
appropriateness 
for 
antiviral treatment to reduce the risk 
of progression to cirrhosis and liver 
cancer; and 
‘‘(II) for regular monitoring of 
liver function and screening for liver 
cancer; and 
‘‘(ii) referral of persons infected with 
acute or chronic hepatitis B for drug and 
alcohol abuse treatment where appropriate. 
‘‘(3) INCREASED
SUPPORT
FOR
HEPATITIS
B 
COORDINATORS.—The Secretary, acting through the 
Director of the Centers for Disease Control and Pre-
vention, shall provide hepatitis B coordinators to 
State, local, and tribal health departments in order 
to enhance the additional management, networking, 
VerDate Aug 31 2005 
06:07 Oct 25, 2007
Jkt 069200
PO 00000
Frm 00012
Fmt 6652
Sfmt 6201
E:\BILLS\H3944.IH
H3944
bajohnson on PROD1PC71 with BILLS
‘‘(3) the training of health care professionals 
and health educators to make them aware of the 
high rates of chronic hepatitis B in certain adult 
ethnic populations, and the importance of preven-
tion, detection, and medical management of hepatitis 
B and of liver cancer screening; 
‘‘(4) the development and distribution of health 
education curricula (including information relating 
to the special needs of individuals infected with hep-
atitis B, such as the importance of prevention and 
early intervention, regular monitoring, and appro-
priate treatment and liver cancer screening) for indi-
viduals providing hepatitis B counseling; 
‘‘(5) support for the implementation curricula 
described in paragraph (4) by State and local public 
health agencies; and 
‘‘(6) the provision of grants for the inclusion of 
viral hepatitis and liver wellness education curricula 
in elementary and secondary school health education 
programs. 
‘‘(c) EPIDEMIOLOGICAL SURVEILLANCE.— 
‘‘(1) IN
GENERAL.—The Secretary, acting 
through the Director of the Centers for Disease 
Control and Prevention, shall support the establish-
ment and maintenance of a national chronic and 
VerDate Aug 31 2005 
06:07 Oct 25, 2007
Jkt 069200
PO 00000
Frm 00014
Fmt 6652
Sfmt 6201
E:\BILLS\H3944.IH
H3944
bajohnson on PROD1PC71 with BILLS
acute hepatitis B surveillance program, in order to 
identify— 
‘‘(A) trends in the incidence of acute and 
chronic hepatitis B; 
‘‘(B) trends in the prevalence of acute and 
chronic hepatitis B infection among groups that 
may be disproportionately affected by hepatitis 
B; and 
‘‘(C) liver cancer and end stage liver dis-
ease incidence and deaths, caused by chronic 
hepatitis B in the various ethnic populations. 
‘‘(2) SEROPREVALENCE
AND
LIVER
CANCER 
STUDIES.—The Secretary, acting through the Direc-
tor of the Centers for Disease Control and Preven-
tion, shall prepare a report outlining the population- 
based seroprevalence studies currently underway, fu-
ture planned studies, the criteria involved in deter-
mining which seroprevalence studies to conduct, 
defer, or suspend, and the scope of those studies, the 
economic and clinical impact of hepatitis B, and the 
impact of hepatitis B on quality of life. Not later 
than one year after the date of enactment of this 
part, the Secretary shall submit the report to the 
Committee on Energy and Commerce of the House 
VerDate Aug 31 2005 
06:07 Oct 25, 2007
Jkt 069200
PO 00000
Frm 00015
Fmt 6652
Sfmt 6201
E:\BILLS\H3944.IH
H3944
bajohnson on PROD1PC71 with BILLS
of Representatives and the Committee on Health, 
Education, Labor, and Pensions of the Senate. 
‘‘(3) CONFIDENTIALITY.—The Secretary shall 
not disclose any individually identifiable information 
identified under paragraph (1) or derived through 
studies under paragraph (2). 
‘‘(d) RESEARCH.—The Secretary, acting through the 
Director of the Centers for Disease Control and Preven-
tion, the Director of the National Cancer Institute, and 
the Director of the National Institutes of Health, shall— 
‘‘(1) conduct community-based research to de-
velop, implement, and evaluate best practices for 
hepatitis B prevention especially in the ethnic popu-
lations with high rates of chronic hepatitis B and 
other high-risk groups; 
‘‘(2) conduct research on hepatitis B natural 
history, pathophysiology, improved treatments, and 
non-invasive tests that helps to predict the risk of 
progression to liver cirrhosis and liver cancer; and 
‘‘(3) conduct research that will lead to better 
non-invasive or blood tests to screen for liver cancer, 
and more effective treatments of liver cancer caused 
by chronic hepatitis. 
‘‘(e) EXPANDED SUPPORT FOR UNDERSERVED AND 
DISPROPORTIONATELY AFFECTED POPULATIONS CHRON-
VerDate Aug 31 2005 
06:07 Oct 25, 2007
Jkt 069200
PO 00000
Frm 00016
Fmt 6652
Sfmt 6201
E:\BILLS\H3944.IH
H3944
bajohnson on PROD1PC71 with BILLS
ICALLY INFECTED WITH HBV.—In carrying out this sec-
tion, the Secretary shall give priority to individuals with 
limited access to health education, testing, and health care 
services and groups that may be disproportionately af-
fected by hepatitis B, including populations such as Asian 
Americans with a high incidence of chronic hepatitis B 
and liver cancer.’’. 
Æ 
VerDate Aug 31 2005 
06:07 Oct 25, 2007
Jkt 069200
PO 00000
Frm 00017
Fmt 6652
Sfmt 6301
E:\BILLS\H3944.IH
H3944
bajohnson on PROD1PC71 with BILLS